Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]pip eridine compound

Details for Australian Patent Application No. 2009313949 (hide)

Owner Theravance, Inc.

Inventors Patterson, Lori Jean; Chao, Robert; Rapta, Miroslav

Agent Davies Collison Cave

Pub. Number AU-A-2009313949

PCT Pub. Number WO2010/056939

Priority 61/114,541 14.11.08 US

Filing date 13 November 2009

Wipo publication date 20 May 2010

International Classifications

C07D 211/22 (2006.01) Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings

A61K 31/4409 (2006.01) - only substituted in position 4, e.g. isoniazid, iproniazid

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

Event Publications

12 May 2011 PCT application entered the National Phase

  PCT publication WO2010/056939 Priority application(s): WO2010/056939

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009313950-Processing biomass

2009313948-Process for preparing 4-[2-(2-fluorophenoxymethyl)phenyl]pip eridine compounds